Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2019

01-02-2019 | Original Article

Three-dimensional indices of renal perfusion in normal pregnancy and pre-eclampsia

Authors: Amanda Ali, Susan Addley, Stephen Ong

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2019

Login to get access

Abstract

Introduction

We compared renal perfusion in normal pregnant women and women with pre-eclampsia using three-dimensional (3D) ultrasound. We measured the flow index (FI), vascular index (VI) and vascularisation flow index (VFI) which are believed to reflect vascularity and flow intensity.

Methods

Fourteen patients with normal pregnancy and 16 patients with pre-eclampsia were recruited. Imaging was conducted using a Voluson E8 machine and a 6-MHz trans-abdominal probe. The inferior border of the maternal left kidney was scanned. Volumes were acquired using 3D power Doppler angiography (3D-PDA). The FI, VI and VFI were generated using ‘histogram’ facility.

Results

Maternal characteristics between normal pregnant women and women with pre-eclampsia were not different in terms of maternal age, gestation or body mass index. Depth of insonnation was not different between groups. The FI, VI and the VFI were not different between groups. The mean (SD) for FI was 27.9 (7.4) vs. 27.1 (6.5) between women with normal pregnancy vs. women with pre-eclampsia. For VI, mean (SD) was 72.3(31.6) vs. 79.4 (28.7) respectively. For VFI, mean (SD) was 20.8 (10.8) vs. 20.8 (8.1) respectively. Using the Mann-Whitney U test, no statistical differences between groups were apparent. There was no correlation between FI measurements and maternal creatinine (Pearson’s R square = 0.04; p = 0.45) or with maternal urea levels (Pearson’s R square = 0.20; p = 0.10).

Conclusion

Using 3D ultrasound, we failed to demonstrate a difference in maternal renal perfusion in normal pregnancy compared to pre-eclampsia. The lack of observed difference may be a reflection of the high variability in 3D measurements (i.e. poor investigative tool) rather than a true lack of difference in renal perfusion.
Literature
1.
go back to reference Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP (2005) Preeclampsia: a renal perspective. Kidney Int 67(6):2101–2113CrossRefPubMed Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP (2005) Preeclampsia: a renal perspective. Kidney Int 67(6):2101–2113CrossRefPubMed
2.
go back to reference Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005CrossRefPubMed Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005CrossRefPubMed
3.
go back to reference Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46(5):1077–1085CrossRefPubMed Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46(5):1077–1085CrossRefPubMed
4.
go back to reference Bahser N, Godehardt E, Hess AP, Blume C (2014) Examination of intrarenal resistance indices indicate the involvement of renal pathology as a significant diagnostic classifier of preeclampsia. Am J Hypertens 27(5):742–749CrossRefPubMed Bahser N, Godehardt E, Hess AP, Blume C (2014) Examination of intrarenal resistance indices indicate the involvement of renal pathology as a significant diagnostic classifier of preeclampsia. Am J Hypertens 27(5):742–749CrossRefPubMed
5.
go back to reference Nakai A, Asakura H, Oya A, Yokota A, Koshino T, Araki T (1999) Pulsed Doppler US findings of renal interlobar arteries in pregnancy-induced hypertension. Radiology 213(2):423–428CrossRefPubMed Nakai A, Asakura H, Oya A, Yokota A, Koshino T, Araki T (1999) Pulsed Doppler US findings of renal interlobar arteries in pregnancy-induced hypertension. Radiology 213(2):423–428CrossRefPubMed
6.
go back to reference Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, Deen WM, Myers BD (1998) Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 54(4):1240–1249CrossRefPubMed Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, Deen WM, Myers BD (1998) Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 54(4):1240–1249CrossRefPubMed
7.
go back to reference Moran P, Baylis PH, Lindheimer MD, Davison JM (2003) Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 14(3):648–652CrossRefPubMed Moran P, Baylis PH, Lindheimer MD, Davison JM (2003) Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 14(3):648–652CrossRefPubMed
8.
go back to reference Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR (2008) Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 32(4):540–550CrossRefPubMed Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR (2008) Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 32(4):540–550CrossRefPubMed
9.
go back to reference Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR (2008) Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 32(4):551–559CrossRefPubMed Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR (2008) Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 32(4):551–559CrossRefPubMed
10.
go back to reference Costa J, Rice H, Cardwell C, Hunter A, Ong S (2010) An assessment of vascularity and flow intensity of the placenta in normal pregnancy and pre-eclampsia using three-dimensional ultrasound. J Matern Fetal Neonatal Med 23(8):894–899CrossRefPubMed Costa J, Rice H, Cardwell C, Hunter A, Ong S (2010) An assessment of vascularity and flow intensity of the placenta in normal pregnancy and pre-eclampsia using three-dimensional ultrasound. J Matern Fetal Neonatal Med 23(8):894–899CrossRefPubMed
11.
go back to reference Anbazhagan A, Ong S (2013) Hepatic portal vein flow and three dimensional indices of hepatic perfusion in pre-eclampsia compared with normal pregnancy. J Obstet Gynaecol 33(8):817–820CrossRefPubMed Anbazhagan A, Ong S (2013) Hepatic portal vein flow and three dimensional indices of hepatic perfusion in pre-eclampsia compared with normal pregnancy. J Obstet Gynaecol 33(8):817–820CrossRefPubMed
12.
go back to reference Guiot C, Gaglioti P, Oberto M, Piccoli E, Rosato R (2008) Todros T. Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies? Ultrasound Obstet Gynecol 31(2):171–176CrossRefPubMed Guiot C, Gaglioti P, Oberto M, Piccoli E, Rosato R (2008) Todros T. Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies? Ultrasound Obstet Gynecol 31(2):171–176CrossRefPubMed
Metadata
Title
Three-dimensional indices of renal perfusion in normal pregnancy and pre-eclampsia
Authors
Amanda Ali
Susan Addley
Stephen Ong
Publication date
01-02-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1844-8

Other articles of this Issue 1/2019

Irish Journal of Medical Science (1971 -) 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine